he Ceplene MAA filing with the EMEA and manufacturing activity relate...Results of Public Offering ...On October 10 2007 EpiCept announced the pricing of a public offerin...Conference Call ...EpiCept will host a conference call to discuss third quarter 2007resu...

he Ceplene MAA filing with the EMEA, and manufacturing activity related to
EPC2407 and EpiCept NP-1.

Results of Public Offering

On October 10, 2007, EpiCept announced the pricing of a public offering
of approximately 4.26 million shares of common stock at $1.88 per share and
five- year warrants to purchase up to approximately 2.13 million shares of
common stock at an exercise price of $1.88 per share. EpiCept received
approximately $7.3 million in net proceeds from the offering. The warrants
will become exercisable beginning six months after the closing. Shares
outstanding at September 30, 2007 amounted to 37,952,289, and after the
private placement increased to 42,210,758.

Conference Call

EpiCept will host a conference call to discuss third quarter 2007
results and provide a business update on Wednesday, November 7, 2007 at
8:30 a.m. EST. To participate in the live call, please dial (888) 802-7346
from the U.S. or Canada or (973) 582-2785 from international locations
(please reference access code 9431155). The conference call will also be
broadcast live on the Internet and may be accessed at
http://www.epicept.com. The webcast will be archived for 90 days.

A telephone replay of the call will be available for seven days by
dialing (877) 519-4471 from the U.S. and Canada or (973) 341-3080 from
international locations (please reference reservation number 9431155).

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer.
EpiCept has a staged portfolio of pharmaceutical product candidates with
several pain therapies in late-stage clinical trials, and a lead oncology
compound for AML with demonstrated efficacy in a Phase III trial; a
marketing authorization application for this compound has been submitted in
Europe. EpiCept is headquartered in Tarrytown, N.Y. Its research and
development team in San Diego is pursuing a drug discovery progra'/>"/>

(Date:7/31/2015)... ... July 31, 2015 , ... ... What are the STASH awards? The Significant Technological Achievements in Secretive Horticulture ... community as well as tried-and-true products that have stood the test of time. ...

(Date:7/31/2015)... ... ... Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, February ... In the two weeks that separate the conference championships and the Super Bowl, there is ... will mark the 50th time it has been held and the festivities will take place ...

(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... its new store run by GoodThreads. The store can be accessed by visiting ... designs, many of which are customizable. The best part: whenever a product is ...

(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug and ... True North Conference Center. The medical community, social workers, law enforcement, and government ... more aligned in the effort to better understand and combat sex trafficking. Lead ...

(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source of ... catch a new and refreshing show on Broadway, look no further than Hamilton. This ... Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille Lortel Award, and New ...

... ... based in Texas, announced today that it has expanded its’ continuum of care with the ... ... Recovery, LLC announced today that it has expanded its’ continuum of care to include Origins ...

... ... , ... pages contained within HR 3200, the House Bill that the recently passed Senate Health Care ... to a cooperative effort between Hearthebill.org and iScroll , developers of the evolutionary new ...

... , Department of Health Urges All Pennsylvanians to Get Vaccinated ... Disease Control and Prevention, or CDC, has allocated a total ... date, the state Department of Health said today. , ... health departments, and state health centers. , The ...

... Calif., Dec. 28 With the New Year just around the ... , Lose weight., Exercise more., ... of most New Year,s resolutions is health-related, many tend to forget ... the doctor. Even more so, we forgo the regular visits to ...

... a role for enhanced activation of the signaling protein ... TSC1 or the TSC2 protein. As indicated by Warren ... accompanying commentary, these data provide a rationale for testing ... TSC-associated tumors. Tuberous sclerosis complex (TSC) is a ...

(Date:7/30/2015)... VANCOUVER , July 30, 2015 OncoGenex ... it will report its second quarter 2015 financial results ... a conference call and live webcast at 4:30 p.m. ... clinical development programs and a general corporate update. ... the Investor Relations page of the OncoGenex website at ...